AOD-9604 is a peptide with a real but modest mechanistic effect on peripheral fat metabolism, supported by Phase II human trial evidence for the standalone compound and not supported by a successful Phase III for standalone obesity treatment
TB-500 (Thymosin Beta-4): Systemic Regeneration Mechanism of Action: TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide in almost all human and animal cells
Weight loss offers no potential benefit to a pregnant woman and may harm the fetus
In other words, it offers a powerful two-for-one benefit
Standard reconstitution uses 23 mL of bacteriostatic water per 5 mg vial of sermorelin and 5 mL per 200600 mg vial of glutathione
A trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with results improving progressively at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, Michigan residents across the state, from Detroit to the Upper Peninsula, have real and practical access to tirzepatide today